[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

ATAI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 30.00%

Insider Buying (Last 12 Months): $1,787,672.04

Insider Selling (Last 12 Months): $0.00

Atai Life Sciences Insider Trading History Chart

Atai Life Sciences Share Price & Price History

^$1.12

▼ -0.02 (-1.75%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Atai Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/16/2023	Florian Brand	Insider	Buy	20,000	$1.16	$23,200.00	130,000
9/13/2023	Florian Brand	Insider	Buy	40,000	$1.45	$58,000.00	110,000
3/29/2023	Apeiron Investment Group Ltd.	Major Shareholder	Buy	1,214,297	$1.32	$1,602,872.04	32,086,697
3/29/2023	Florian Brand	Insider	Buy	70,000	$1.48	$103,600.00	70,000
4/29/2022	Apeiron Investment Group Ltd.	Major Shareholder	Buy	21,900	$4.47	$97,893.00	1,799,302
4/27/2022	Apeiron Investment Group Ltd.	Major Shareholder	Buy	19,803	$4.64	$91,885.92	1,742,702
4/25/2022	Apeiron Investment Group Ltd.	Major Shareholder	Buy	8,961	$4.78	$42,833.58	1,676,692
4/22/2022	Apeiron Investment Group Ltd.	Major Shareholder	Buy	52,820	$4.83	$255,120.60	1,667,731
4/18/2022	Apeiron Investment Group Ltd.	Major Shareholder	Buy	54,322	$5.11	$277,585.42	1,413,205
4/14/2022	Apeiron Investment Group Ltd.	Major Shareholder	Buy	4,967	$5.19	$25,778.73	1,358,883
4/11/2022	Apeiron Investment Group Ltd.	Major Shareholder	Buy	53,926	$4.83	$260,462.58	1,298,719
4/8/2022	Apeiron Investment Group Ltd.	Major Shareholder	Buy	57,689	$4.81	$277,484.09	1,244,793

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Atai Life Sciences (NASDAQ:ATAI)

9.16% of Atai Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Atai Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Legal & General Group Plc	60,360	$78K	0.0%	-33.8%	0.036%
11/14/2023	Qube Research & Technologies Ltd	27,290	$35K	0.0%	-23.6%	0.016%
11/8/2023	HighTower Advisors LLC	46,576	$60K	0.0%	-23.6%	0.028%
11/6/2023	AdvisorShares Investments LLC	178,523	$0.23M	0.1%	+11.6%	0.108%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	631,710	$0.82M	0.0%	+16.1%	0.381%
10/20/2023	Hunter Perkins Capital Management LLC	19,241	$25K	0.0%	N/A	0.012%
8/15/2023	XTX Topco Ltd	226,761	$0.39M	0.1%	-33.1%	0.137%
8/15/2023	Goldman Sachs Group Inc.	62,093	$0.11M	0.0%	-36.2%	0.037%
8/14/2023	Tower Research Capital LLC TRC	30,566	$53K	0.0%	+98.3%	0.018%
8/14/2023	State Street Corp	878,220	$1.51M	0.0%	+85.1%	0.529%
8/14/2023	Cerity Partners LLC	924,999	$1.59M	0.0%	-31.2%	0.557%
8/11/2023	Credit Suisse AG	420,801	$0.72M	0.0%	+34.6%	0.253%
8/11/2023	BlackRock Inc.	2,459,911	$4.23M	0.0%	+16.0%	1.482%
8/11/2023	Geode Capital Management LLC	150,536	$0.26M	0.0%	+28.4%	0.091%
8/11/2023	Tejara Capital Ltd	290,215	$0.50M	0.2%	+7.1%	0.175%
8/11/2023	JPMorgan Chase & Co.	90,305	$0.16M	0.0%	+1,175.7%	0.054%
8/11/2023	Northern Trust Corp	147,343	$0.25M	0.0%	+9.6%	0.089%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	544,311	$0.94M	0.0%	-10.6%	0.328%
8/7/2023	XML Financial LLC	22,067	$38K	0.0%	+58.9%	0.013%
8/3/2023	Barclays PLC	275,131	$0.47M	0.0%	+8.9%	0.166%
8/2/2023	North Star Investment Management Corp.	15,430	$27K	0.0%	N/A	0.009%
7/31/2023	Daiwa Securities Group Inc.	21,315	$37K	0.0%	+4,454.5%	0.013%
7/27/2023	Virtu Financial LLC	23,634	$41K	0.0%	N/A	0.014%
7/19/2023	Teacher Retirement System of Texas	33,779	$58K	0.0%	-11.9%	0.020%
7/17/2023	Wedmont Private Capital	27,419	$55K	0.0%	N/A	0.017%
7/10/2023	SG Americas Securities LLC	41,797	$72K	0.0%	-37.6%	0.025%
5/16/2023	M Holdings Securities Inc.	31,060	$56K	0.0%	+51.8%	0.019%
5/16/2023	Ruane Cunniff & Goldfarb L.P.	42,112	$76K	0.0%	N/A	0.025%
5/16/2023	State Street Corp	474,559	$0.86M	0.0%	+5.7%	0.286%
5/15/2023	Cubist Systematic Strategies LLC	40,246	$73K	0.0%	-83.4%	0.024%
5/15/2023	Two Sigma Advisers LP	462,100	$0.84M	0.0%	+6.8%	0.278%
5/15/2023	Two Sigma Investments LP	852,714	$1.54M	0.0%	-12.5%	0.514%
5/15/2023	Freestone Capital Holdings LLC	20,000	$36K	0.0%	+100.0%	0.012%
5/15/2023	XTX Topco Ltd	338,754	$0.61M	0.1%	+241.4%	0.204%
5/12/2023	Renaissance Technologies LLC	573,100	$1.04M	0.0%	N/A	0.345%
5/12/2023	BlackRock Inc.	2,120,801	$3.84M	0.0%	+10.5%	1.278%
5/12/2023	Bank of America Corp DE	582,594	$1.05M	0.0%	+529.4%	0.351%
5/12/2023	HRT Financial LP	38,525	$69K	0.0%	N/A	0.023%
5/12/2023	UBS Group AG	29,755	$54K	0.0%	-20.9%	0.018%
5/12/2023	Tejara Capital Ltd	271,000	$0.49M	0.3%	+26.4%	0.163%
5/12/2023	HighTower Advisors LLC	73,114	$0.13M	0.0%	+68.4%	0.044%
5/11/2023	American Century Companies Inc.	23,893	$38K	0.0%	+28.3%	0.014%
5/11/2023	Robertson Stephens Wealth Management LLC	16,721	$30K	0.0%	-47.1%	0.010%
5/10/2023	Simplify Asset Management Inc.	140,000	$0.25M	0.0%	N/A	0.084%
5/10/2023	Swiss National Bank	268,600	$0.49M	0.0%	-8.3%	0.162%
5/9/2023	Resolute Advisors LLC	16,777	$30K	0.0%	-60.0%	0.010%
5/9/2023	Tower Research Capital LLC TRC	15,415	$28K	0.0%	-29.0%	0.009%
5/9/2023	AdvisorShares Investments LLC	160,337	$0.29M	0.1%	-22.9%	0.097%
5/9/2023	Russell Investments Group Ltd.	29,000	$52K	0.0%	N/A	0.017%
5/4/2023	Barclays PLC	252,717	$0.46M	0.0%	+184.0%	0.152%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	608,534	$1.10M	0.0%	+37.5%	0.367%
4/28/2023	SG Americas Securities LLC	67,027	$0.12M	0.0%	-17.4%	0.040%
2/15/2023	CI Private Wealth LLC	14,750	$39K	0.0%	N/A	0.009%
2/15/2023	Jane Street Group LLC	17,961	$48K	0.0%	-29.1%	0.011%
2/15/2023	Cerity Partners LLC	1,344,199	$3.58M	0.0%	N/A	0.810%
2/15/2023	Tejara Capital Ltd	214,400	$0.57M	0.3%	N/A	0.129%
2/15/2023	State of Wisconsin Investment Board	114,344	$0.30M	0.0%	-5.9%	0.069%
2/15/2023	Schonfeld Strategic Advisors LLC	472,100	$1.26M	0.0%	+449.0%	0.285%
2/15/2023	Millennium Management LLC	1,240,548	$3.30M	0.0%	+37.8%	0.748%
2/15/2023	Morgan Stanley	2,415,035	$6.42M	0.0%	+3.1%	1.456%
2/15/2023	Man Group plc	62,840	$0.17M	0.0%	+211.1%	0.038%
2/15/2023	Mariner LLC	11,423	$30K	0.0%	N/A	0.007%
2/15/2023	Alps Advisors Inc.	112,628	$0.30M	0.0%	N/A	0.068%
2/14/2023	Alpine Global Management LLC	43,664	$0.12M	0.0%	N/A	0.026%
2/14/2023	Two Sigma Investments LP	974,592	$2.59M	0.0%	+29.5%	0.588%
2/14/2023	Engineers Gate Manager LP	13,616	$36K	0.0%	N/A	0.008%
2/13/2023	Credit Suisse AG	312,686	$0.83M	0.0%	-3.4%	0.189%
2/13/2023	Geode Capital Management LLC	117,226	$0.31M	0.0%	+376.6%	0.071%
2/13/2023	American Century Companies Inc.	18,627	$50K	0.0%	N/A	0.011%
2/13/2023	JPMorgan Chase & Co.	20,440	$55K	0.0%	+73.3%	0.012%
2/10/2023	Bank of America Corp DE	92,567	$0.25M	0.0%	-6.8%	0.056%
2/10/2023	Resolute Advisors LLC	41,944	$0.11M	0.0%	N/A	0.025%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	442,618	$1.18M	0.0%	-1.5%	0.267%
2/8/2023	Swiss National Bank	293,000	$0.78M	0.0%	+3.2%	0.177%
2/7/2023	Commonwealth Equity Services LLC	31,881	$84K	0.0%	N/A	0.019%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	28,085	$72K	0.0%	+27.5%	0.017%
1/27/2023	Exchange Traded Concepts LLC	27,893	$74K	0.0%	+64.3%	0.017%
1/24/2023	ARK Investment Management LLC	5,663,340	$15.06M	0.1%	-7.7%	3.414%
1/18/2023	Exchange Traded Concepts LLC	27,893	$74K	0.0%	+64.3%	0.017%
1/17/2023	Hunter Perkins Capital Management LLC	23,241	$61K	0.0%	+48.3%	0.014%
1/13/2023	Gofen & Glossberg LLC IL	10,300	$27K	0.0%	N/A	0.006%
11/16/2022	Balyasny Asset Management LLC	29,915	$99K	0.0%	N/A	0.018%
11/16/2022	Jane Street Group LLC	25,348	$84K	0.0%	N/A	0.015%
11/16/2022	BNP Paribas Arbitrage SNC	99,147	$0.33M	0.0%	N/A	0.060%
11/15/2022	State Street Corp	106,829	$0.35M	0.0%	+102.9%	0.064%
11/15/2022	Two Sigma Advisers LP	252,400	$0.84M	0.0%	+28.6%	0.152%
11/15/2022	Two Sigma Investments LP	752,631	$2.49M	0.0%	+2.8%	0.454%
11/15/2022	UBS Asset Management Americas Inc.	42,569	$0.14M	0.0%	-32.8%	0.026%
11/15/2022	Vanguard Group Inc.	484,567	$1.60M	0.0%	+0.8%	0.292%
11/15/2022	Marshall Wace LLP	43,933	$0.15M	0.0%	N/A	0.026%
11/15/2022	Ensign Peak Advisors Inc	15,030	$50K	0.0%	N/A	0.009%
11/15/2022	BlackRock Inc.	1,547,100	$5.12M	0.0%	+24.1%	0.933%
11/14/2022	Royal Bank of Canada	50,372	$0.17M	0.0%	-13.5%	0.030%
11/14/2022	Cubist Systematic Strategies LLC	103,095	$0.34M	0.0%	+43.8%	0.062%
11/14/2022	Renaissance Technologies LLC	248,300	$0.82M	0.0%	-42.0%	0.150%
11/14/2022	Hsbc Holdings PLC	16,992	$57K	0.0%	N/A	0.010%
11/14/2022	Pictet Asset Management SA	14,052	$47K	0.0%	N/A	0.008%
11/10/2022	Credit Suisse AG	323,755	$1.07M	0.0%	+3.2%	0.195%
11/10/2022	Tower Research Capital LLC TRC	12,980	$43K	0.0%	+337.3%	0.008%
11/7/2022	Virtu Financial LLC	45,990	$0.15M	0.0%	N/A	0.028%

Data available starting January 2016

ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; GRX-917, a deuterated etifoxine for anxiety disorders; VLS-01 a N,N-Dimethyltryptamine for treatment resistant depression (TRD); DMX-1002, an oral formulation of ibogaine, a cholinergic, glutamatergic and monoaminergic receptor modulator that is a naturally occurring psychedelic product isolated from a West African shrub for the treatment of opioid use disorders (OUD); and EMP-01, an oral formulation of an MDMA derivative being developed for the treatment of post-traumatic stress disorder. The company's other clinical programs comprise PCN-101, a subcutaneous formulation of R-ketamine, as a therapy for psychiatric indications initially focused on TRD; and KUR-101, a formulation of deuterated mitragynine for the treatment of OUD. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany with offices in New York and London.

Today's Range

Now: $1.12

$1.06

$1.15

50 Day Range

MA: $1.24

$1.06

$1.52

52 Week Range

Now: $1.12

$1.05

$3.65

Volume

1,352,721 shs

Average Volume

996,902 shs

Market Capitalization

$185.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Atai Life Sciences?: Atai Life Sciences' top insider shareholders include:
Apeiron Investment Group Ltd (Major Shareholder)
Florian Brand (Insider)
Learn More about top insider investors at Atai Life Sciences.
Who are the major institutional investors of Atai Life Sciences?: Atai Life Sciences' top institutional shareholders include:
Mirae Asset Global Investments Co. Ltd. — 0.38%
AdvisorShares Investments LLC — 0.11%
Legal & General Group Plc — 0.04%
HighTower Advisors LLC — 0.03%
Qube Research & Technologies Ltd — 0.02%
Hunter Perkins Capital Management LLC — 0.01%
Learn More about top institutional investors of Atai Life Sciences stock.
Which institutional investors are selling Atai Life Sciences stock?: Within the previous quarter, ATAI stock was sold by these institutional investors:
Legal & General Group Plc
HighTower Advisors LLC
Qube Research & Technologies Ltd
Which institutional investors are buying Atai Life Sciences stock?: In the last quarter, ATAI stock was acquired by institutional investors including:
Mirae Asset Global Investments Co. Ltd.
Hunter Perkins Capital Management LLC
AdvisorShares Investments LLC
During the previous year, these company insiders have bought Atai Life Sciences stock:
Apeiron Investment Group Ltd (Major Shareholder)
Florian Brand (Insider)
Learn More investors buying Atai Life Sciences stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

ATAI Insider Trading

Atai Life Sciences Insider Trading History Chart

Atai Life Sciences Share Price & Price History

Atai Life Sciences Insider Trading History

SEC Filings (Institutional Ownership Changes) for Atai Life Sciences (NASDAQ:ATAI)

Institutional Buying and Selling by Quarter

Atai Life Sciences Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Atai Life Sciences?

Who are the major institutional investors of Atai Life Sciences?

Which institutional investors are selling Atai Life Sciences stock?

Which institutional investors are buying Atai Life Sciences stock?